1
|
Correa-Padilla E, Hernández-Cano A, Cuevas G, Acevedo-Betancur Y, Esquivel-Guadarrama F, Martinez-Mayorga K. Modifications in the piperazine ring of nucleozin affect anti-influenza activity. PLoS One 2023; 18:e0277073. [PMID: 36763579 PMCID: PMC9916566 DOI: 10.1371/journal.pone.0277073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2022] [Accepted: 01/12/2023] [Indexed: 02/11/2023] Open
Abstract
The infection caused by the influenza virus is a latent tret. The limited access to vaccines and approved drugs highlights the need for additional antiviral agents. Nucleozin and its analogs have gain attention for their promising anti-influenza activity. To contribute to the advancement of the discovery and design of nucleozin analogs, we analyzed piperazine-modified nucleozin analogs to increase conformational freedom. Also, we describe a new synthetic strategy to obtain nucleozin and its analogues, three molecules were synthesized and two of them were biologically evaluated in vitro. Although the analogues were less active than nucleozin, the loss of activity highlights the need for the piperazine ring to maintain the activity of nucleozin analogs. Interestingly, this result agrees with the prediction of anti-influenza activity made with a QSAR model presented in this work. The proposed model and the synthetic route will be useful for the further development of nucleozin analogs with antiviral activity.
Collapse
Affiliation(s)
- Erick Correa-Padilla
- Institute of Chemistry, National Autonomous University of Mexico, Mexico City, Mexico
- Zaragoza School of Higher Education, National Autonomous University of Mexico, Mexico City, Mexico
| | - Alejandro Hernández-Cano
- Institute of Chemistry, National Autonomous University of Mexico, Mexico City, Mexico
- School of Science, National Autonomous University of Mexico, Mexico City, Mexico
| | - Gabriel Cuevas
- Institute of Chemistry, National Autonomous University of Mexico, Mexico City, Mexico
| | - Yunuen Acevedo-Betancur
- School of Medicine, Autonomous University of the State of Morelos, Cuernavaca, Morelos, México
| | | | - Karina Martinez-Mayorga
- Institute of Chemistry, National Autonomous University of Mexico, Mexico City, Mexico
- Institute of Chemistry, Campus Merida, National Autonomous University of Mexico, Merida-Tetiz Highway, Yucatán, México
- Institute for Applied Mathematics and Systems, Merida Research Unit, National Autonomous University of Mexico, Sierra Papacal Merida, Yucatan, Mexico
- * E-mail:
| |
Collapse
|
2
|
Meanwell NA, Loiseleur O. Applications of Isosteres of Piperazine in the Design of Biologically Active Compounds: Part 1. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2022; 70:10942-10971. [PMID: 35675050 DOI: 10.1021/acs.jafc.2c00726] [Citation(s) in RCA: 22] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Piperazine and homopiperazine are well-studied heterocycles in drug design that have found gainful application as scaffolds and terminal elements and for enhancing the aqueous solubility of a molecule. The optimization of drug candidates that incorporate these heterocycles in an effort to refine potency, selectivity, and developability properties has stimulated the design and evaluation of a wide range of bioisosteres that can offer advantage. In this review, we summarize the design and application of bioisosteres of piperazine and homopiperazine that have almost exclusively been in the drug design arena. While there are ∼100 approved drugs that incorporate a piperazine ring, only a single marketed agricultural product is built on this heterocycle. As part of the review, we discuss some of the potential reasons underlying the relatively low level of importance of this heterocycle to the design of agrochemicals and highlight the potential opportunities for their use in contemporary research programs.
Collapse
Affiliation(s)
- Nicholas A Meanwell
- Small Molecule Drug Discovery, Bristol Myers Squibb Research and Early Development, PO Box 4000, Princeton, New Jersey 08543, United States
| | - Olivier Loiseleur
- Syngenta Crop Protection Research, Schaffhauserstrasse, Stein CH-4332, Switzerland
| |
Collapse
|